* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download One heartbeat at a time.
Survey
Document related concepts
Remote ischemic conditioning wikipedia , lookup
Cardiac contractility modulation wikipedia , lookup
Saturated fat and cardiovascular disease wikipedia , lookup
Heart failure wikipedia , lookup
Management of acute coronary syndrome wikipedia , lookup
Antihypertensive drug wikipedia , lookup
Electrocardiography wikipedia , lookup
Baker Heart and Diabetes Institute wikipedia , lookup
Cardiovascular disease wikipedia , lookup
Rheumatic fever wikipedia , lookup
Quantium Medical Cardiac Output wikipedia , lookup
Coronary artery disease wikipedia , lookup
Heart arrhythmia wikipedia , lookup
Dextro-Transposition of the great arteries wikipedia , lookup
Transcript
2010 | Annual Report One heartbeat at a time. It is time. Time matters. Time with our loved ones. Time to accomplish the work and relish the joys of the world. Time truly matters when you are having a heart attack…when your child is living with cardiovascular disease…when someone you love is waiting for a heart transplant. Time matters because risk factors for heart disease — obesity and diabetes — are rising swiftly in the United States and globally. Time matters because heart disease is now the number one cause of death around the world. The Minneapolis Heart Institute Foundation is committed to stopping this disease, and we are making significant progress. Through innovative education programs and groundbreaking research, we are discovering how to prevent and treat heart disease at ever-earlier stages. Established in 1982 by a group of Minneapolis Heart Institute® physicians, we have a vitally important mission: To promote and improve cardiovascular health, quality of life and longevity for all. The community supports this mission through philanthropic giving. We are indebted to all of you and we look forward to sharing our achievements with you as we move forward in new directions. it is time to ta ke fiv e ! in reducing your risk of heart S c i e nAchieving t ifi c aIhealthy n n o body v a tweight i o n is&a key R efactor s e ar ch disease. The Take Five Community Health Challenge, developed by Hearts The Minneapolis Heart Foundation is one gives of theyou nation’s topsteps ten centers Beat Back: The Institute Heart of New Ulm Project, five easy you canfor cardiovascular research and education. Conducting more than 120 peer-reviewed studies take to reduce or maintain your weight today. annually, MHIF is a recognized research leader in the broadest range of cardiovascular medicine including: hypertrophic cardiomyopathy, adult stem cell therapy, acute myocardial infarction, electrophysiology, heart failure, imaging, peripheral artery disease, and prevention. Each year, cardiologists and hospitals from around the world adopt MHIF protocols to improve patient care. r u ynog g i seeasntaiinnitnain i E d u c at i o n & O u t r e a c h t ddeso mtoaima r t it t it eeaarbehaviors . y. mmm s. can significantly Research shows that modifying specific health h ay da reduce the risk of m d o k tt h cor c ee programs, screenings h ch developing heart disease. Through our and presentations, rs os. w asc ea eenncommunity . o e . k 2 v k s s e d k e l 1 e e d v e n we educate diverse audiences about health. eThe e goal ofbl our b community outreach is to eheart unouweext wea w prprfactors tageta necessary to assist individuals n aprovide e po5 p12eand increase personal awareness of orisk the tools s g e o se 5seext th aysday ve& v y. ay. spts t lolifestyles. & lonver 5 d 5 in their pursuit of heart-healthy s t p s i da d ete al toalrttohhet o tivective ufitfru acheach t r f eivsetsaegtoat goovweeigllycaalcly aay.day. gsinogf s orseulfrseelf v fi fS.eSeigyhour ysihcaysi s aeds a ervsienrv yoruyo 1. 1 w e pBhe p timetim t 5sst 5 s fors fo e 5 2B. at E5at leatslea utienut . n 2 E. t atat a mi m 3. 3 E.a E ke a5ke 5 rg.org 4. 4 T.a T arte.aort o 5. 5 lshpelsh pr pm a m in e ase ke F ive! E VV E o Ta er t m in e nt pla ce so you rem e mb kee ak tta I FFI n ag m s thi t Pu et One heartbeat at a time. The Minneapolis Heart Institute Foundation’s mission is to promote and improve cardiovascular health, quality of life and longevity for all. Creating a world without heart disease® S c i e n t i f i c I n n o vat i o n & R e s e a r c h The Minneapolis Heart Institute Foundation is one of the nation’s top ten centers for cardiovascular research and education. Publishing more than 120 peer-reviewed studies annually, MHIF is a recognized research leader in the broadest range of cardiovascular medicine including: hypertrophic cardiomyopathy, adult stem cell therapy, acute myocardial infarction, electrophysiology, heart failure, imaging, peripheral artery disease and prevention. Each year, cardiologists and hospitals around the world adopt MHIF protocols to save lives and improve patient care. E d u c at i o n & O u t r e a c h Research shows that modifying specific health behaviors can significantly reduce the risk of developing heart disease. Through our community programs, screenings and presentations, we educate people of all walks of life about heart health. The goal of our community outreach is to increase personal awareness of risk factors and provide the tools necessary to help people pursue heart-healthy lifestyles. Time to reflect. In 2010, MHIF made headlines with its significant outcomes in cardiovascular research and education. Our work is consistently featured in highly respected journals and media outlets including the Journal of the American Medical Association, Circulation, the New York Times, Wall Street Journal, and the New England Journal of Medicine. A quick glance at some of the headlines… A dvan cin g A d u lt S t e m C e l l T he r apy Making Advances in Adult Stem Cell Therapy MHIF researcher Jay H. Traverse, MD, published a study in the September issue of the American Heart Journal demonstrating that adult bone-marrow stem cells are safe in treating acute myocardial infarction (heart attack). MHIF is a member of the National Institutes of Healthfunded Cardiovascular Cell Therapy Research Network. This consortium of five centers across the United States is dedicated to studying stem cell therapy in the treatment of heart disease. MHIF is treating the largest number of heart patients using adult stem cell therapy in the United States. Tackling the Leading Killer of Women HEALTH NEWS Tackling the Leading Killer of Women Science Review Kim’s Story Atrial Fibrillation in Infants MHIF co-hosted a two-day summit for medical professionals and thought leaders in April 2010 entitled Women and Heart Disease: A Summit to Eliminate Untimely Deaths in Women. The conference highlighted and explored gender disparities in heart attack symptoms, diagnosis and treatment, and examined efforts to raise community awareness of women’s risk for heart disease. Given her young age and healthy lifestyle, Kim never thought she would have a heart attack. Read Kim’s story at mplsheart.org/2010annualreport. I m p rov in g Tr e at m e n t fo r Irr e g u l ar H e art be ats Atrial fibrillation is a heart rhythm problem often treated with ablation, a procedure that interrupts abnormal electrical pathways in the heart muscle. Ablation is an effective treatment for the disorder, but can cause post-treatment pain. Preliminary results from an MHIF pilot study by Daniel Melby, MD, show that using a steroid after ablation can reduce pain and may even keep atrial fibrillation from recurring. Pr ev e n t in g H e art At tack s B e fo r e T hey O ccu r MHIF conducted one of the first studies to look at patients before they have a heart attack. The study, led by Kevin J. Graham, MD, demonstrates that most first-time heart attacks can be prevented. Evidence from this study suggests that high-risk patients often disregard medical advice and are not identified and treated for the early onset of their disease. These findings should help in earlier identification of these patients, decreasing their risk of heart attack. Br e ak in g T hro u g h B lo ck e d Art e r ie s An MHIF trial led by M. Nicholas Burke, MD, is looking at a novel approach to opening totally blocked arteries — the most challenging to treat. The study demonstrates the safety and effectiveness of a new system to prepare a blocked artery for angioplasty, which opens the artery with an inflated balloon, and for placement of a stent, which keeps the artery open. Saving lives and improving health. With every heartbeat. The Minneapolis Heart Institute Foundation follows your heart and the hearts of those you love through every life stage. We educate your children and grandchildren on heart-healthy lifestyle choices. We are here for you with the most innovative therapies when you or a loved one has a heart attack. And we provide options to improve your quality of life even when your heart is failing. Following Your Heart Through Every Life Stage Pre-Birth Birth Childhood Genetic Arrhythmia Hypertrophic Cardiomyopathy (HCM) Imaging Girls and Moms on the Move A n sw e rs f o r a n I n h e r i t e d H e a rt D i s e a s e Pre-Birth Late Adulthood Led by William T. Katsiyiannis, MD, MHIF established the Genetic Arrhythmia Center in 2008. It serves patients and families affected by rare genetic arrhythmias – altered heart rhythms and heart rates that carry serious health risks, including cardiac arrest and death. The center gives hope to families asking, “Who’s next?”. Through genetic testing and counseling, family members are given access to the latest treatment, diagnosis and monitoring options. Dostal’s Story The Genetic Arrhythmia Center has given hope to countless families. Read the Dostal family’s story at mplsheart.org/2010annualreport. H e a lt h y C o n n e c t i o n s : G i r l s a n d M o m s o n t h e M o v e Childhood The preteen years are tough on young girls. Societal pressures along with emotional and physical changes make it especially important to encourage healthy behaviors. Girls and Moms on the Move is a six-week program designed to do just that. The program gives mothers and daughters (aged 8-12 years) the opportunity to get healthy, be active and have fun together. It combines educational presentations and experiences with group physical activity sessions and culminates in a 5K walk or run. Piloted in 2009, workshops were offered this year in communities throughout the Twin Cities, outstate Minnesota and Iowa. Early Adulthood Middle-Age Lead Safety The Heart of New Ulm Project Women on the Move OPTIMIST Program Vascular/Endovascular Therapies Heart Attack Treatment Systems of Care Late Adulthood Heart Failure Therapies Valvular Heart Therapies c lo s i n g i n o n t h e n u m b e r o n e c au s e o f s u d d e n d e at h i n y o u n g p e o p l e Pre-Birth Late Adulthood Hypertrophic cardiomyopathy (HCM) is a thickening of the heart muscle that inhibits the outflow of blood. HCM affects approximately one in 500 people. Thanks to the pioneering work of Barry J. Maron, MD, director of the MHIF Hypertrophic Cardiomyopathy Center, HCM is now a treatable condition that can be managed with drugs, implantable defibrillators, pacemakers, surgery and ablation, as well as genetic counseling. Dr. Maron has published more than 800 articles on this condition (31 in 2010 alone) in prestigious journals such as Circulation, the New England Journal of Medicine and the Journal of the American Medical Association. Hearts B e at B ac k : The Heart of New Ulm Project Early Adulthood Late Adulthood 2011 marks the third year of MHIF’s ambitious pilot program that continues to receive national attention for its innovative strategies to reduce heart attacks in an entire town. Partnering with Allina Hospitals & Clinics, New Ulm Medical Center and the entire city of New Ulm, we teach heart-healthy behaviors that improve nutrition, increase exercise and stop tobacco use. • In 2010, we launched our first Community Health Challenge, dividing the city into districts and recruiting volunteer health leaders in each neighborhood. The result has been a surge in activity levels, with districts hosting dance events, walking clubs and more. • We also launched the HeartBeat Connections program that targets the 1,500 people at highest risk for a heart attack. The program provides aggressive medical intervention to manage blood pressure and cholesterol levels. In 2011, our focus is on reducing New Ulm’s 73% obesity rate, with the Take Five Challenge that promotes five easy actions community members can take to reduce or maintain weight. 94% of New Ulm community adults say they believe that the Heart of New Ulm Project will be successful in its mission to reduce heart attacks. Taking the “Lead” on Patient Safety: Electrophysiology Early Adulthood Late Adulthood MHIF researcher Robert G. Hauser, MD, is a strong advocate for patient safety. In 2010, Dr. Hauser published a study looking at the safety of two common leads, which are the electrodes in implanted cardioverter defibrillators (ICDs) that correct faulty heart rhythms. His highly publicized work is helping physicians across the country make tough decisions for patients with these leads. Sav i ng H e a rt M us c le : I n n ovat iv e H e art At tack Tr e at m e n t Middle Age Late Adulthood Research demonstrates that the rapid return of blood to the heart after opening a clogged artery may cause damage to heart muscle. In a study funded by the National Institutes of Health, MHIF researcher Jay H. Traverse, MD, is testing a technique called postconditioning which slows down this rapid flow. This therapy has great potential to lessen the damage to the heart, reducing a patient’s risk of heart failure. I m a g i n g : A dva n c i n g t h e S c i e n c e o f C a r d i o va s c u l a r Disease Diagnosis Pre-Birth Late Adulthood MHIF houses the world’s largest database of MRI-CT images. These images help physicians define and understand different types of vessel blockages, among many other applications, and are instrumental in guiding patient care. MHIF researcher and Director of Education Robert S. Schwartz, MD, is using imaging to study the effects of marathon running on men’s and women’s coronary arteries. 210 Miles 100 Miles 50 Miles Sy ste m s o f C a r e : Acc e l e r at in g Tr e atm e nt, S avi ng L i ve s Middle Age Late Adulthood MHIF develops protocols that significantly accelerate and improve emergency care. These include: Sarah’s Story • Level 1– Patients with certain types of heart attacks are much more likely to recover if treated with angioplasty within 90 minutes. This procedure is easily accessible in a large metro area hospital, but not in outlying rural areas. MHIF’s Level 1 program, developed by MHIF Director of Research Timothy D. Henry, MD, creates a standardized system that quickly and efficiently moves the patient from their local hospital to a Level 1 hospital for fast intervention. The result: people who live within a 210-mile radius of a Level 1 catheterization lab can now experience the same care as those who live right next door. • Cool It – Quickly cooling body temperature through therapeutic hypothermia can help reduce the risk of neurological damage in cardiac arrest patients. MHIF researchers led by Michael R. Mooney, MD, have developed the Cool It protocol which ensures that this therapy happens immediately when a patient presents with cardiac arrest. In 2010, MHIF hosted the conference, Miracle on Ice, to educate medical professionals and to advocate for the use of the therapy in hospitals across the country. Sarah feels blessed to live in a community where advanced therapies like Cool It are available. Read her story at mplsheart.org/2010annualreport. • Aortic Dissection – Aortic dissection, a tear in the inner lining of the aorta, is a rare but deadly medical emergency. Accelerating the time between the patient’s arrival in the hospital and intervention is critical because every second counts. An MHIF study led by Kevin M. Harris, MD, resulted in a 43% reduction in the time from diagnosis to intervention, which potentially will save countless lives. MHIF researcher Timothy M. Sullivan, MD, is also looking at less invasive methods for treating another potentially dangerous condition called an abdominal aortic aneurysm. These new techniques can greatly reduce the risk of more invasive surgery. OPTION S FOR A FAILING HEA RT: ADVANCED HEA RT FAILUR E THE R APIE S Late Adulthood More than 3,100 patients are on the heart transplant list. Of these, only 2,200 will receive hearts. To help those patients waiting for a transplant, MHIF is researching mechanical pumps called left ventricular assist devices (LVADs) that improve the heart’s own pumping function. Current research led by David S. Feldman, MD, PhD, and Benjamin Sun, MD, is also looking at the potential for making LVADs a long term option for patients who are not eligible for a heart transplant. Marrel’s Story An LVAD greatly improved Marrel’s quality of life as he waited for a heart transplant. Read his story at mplsheart.org/2010annualreport. VALVE CLINIC : R E S TO R ING HOPE , IMP ROVING Q UALITY OF LIFE Late Adulthood MHIF is at the forefront of innovative therapies for complex valve disorders. Under the leadership of MHIF researcher Wesley R. Pedersen, MD, a team of caregivers has created the Valve Clinic to provide an integrated approach to patient care and research. We are currently involved in a pioneering study that could greatly improve the outlook for older, less healthy patients who are not good candidates for open heart surgery. Financial Highlights Au d i t e d S u m m a r y o f R e v e n u e & E x p e n s e s 2 0 1 0 Revenues Operations Time or Purpose Restricted Funds Endowments Contributions, 40% Sponsorships, and Grants $4,308,348 $681,086 $41,177 $3,408,338 - - 2,512 $ 1,762,830 Research Study Revenues 31% Investments/Trusts Change in Value Licensing Fees 0% $ 6,990 7% $ 746,280 - - Income from Services 2% $213,600 - - Payout from Endowments 5% $ 545,565 - $ (545,565) $1,618,112 $ (1,618,112) - Release of Time and 15% Purpose Restricted Funds Sources of Revenue $10,847,233 $ $ (934,514) $ 1,258,442 Expenses Program Services $ ,2,220,541 Education 22% - - $ 5,969,898 Research 60% - - - - $ 930,738 Fundraising 9% - - 866,610 - - Total Supporting $ 1,797,348 - - Board Designated Fund $ (450,000) $ 450,000 - Total Program $ 8,190,439 Supporting Services Administration9% Change in Net Assets $ $ 409,446 $ (484,514) $ 1,258,442 Au d i t e d b a l a n c e s h e e t, d e c e m b e r 3 1 , 2 0 1 0 Assets Liabilities Net Assets Cash & Equivalents $ 3,719,770 Accounts Payable $ 444,290 Unrestricted $ 1,661,876 Investments $ 16,776,860 Accrued Payroll $ 431,380 $ 3,485,914 Contributions Receivable $ Accrued Pension $ 351,120 Unrestricted - Board Designated Endowment Pledges Receivable $ 1,365,158 Other Accrued Expenses $ 390,060 Temporarily Restricted $ 3,938,615 Other Receivables $ 1,304,860 Annuity Payment Liability $ 157,370 Restricted $ 12,495,284 Other Assets $ 23,396 Accrued Rent $ 198,810 Total Net Assets $ 21,581,689 Fixed Assets (net) $ 401,265 Deferred Revenue $ 102,650 TOTAL ASSETS $23,657, 369 TOTAL LIABILITIES $2,075,680 TOTAL LIABILITIES & NET ASSETS $23,657, 369 66,060 Board of Directors Phil Ankeny Ann Bentdahl, Vice Chair Forrest Burke M. Nicholas Burke, MD, Chair Barbara Burwell Bradley Chapin Deborah Dixson Barbara Spell Dovolis Marna Fullerton Tamarra Giertz, Secretary Morris Goodwin, Jr Kevin J. Graham, MD Elizabeth Z. Grey, MD Robert G. Hauser, MD Morrison Hodges, MD Benjamin Jaffray Jerry Johnson, Treasurer William T. Katsiyiannis, MD D. William Kaufman Thomas A. Keller, III Maureen Kucera-Walsh Casey M. Lawler, MD Rick Leggott Richard Meyer, Ex-Officio Michael R. Mooney, MD Stuart Nolan, Past Chair Cindy Piper Colleen Sargent Robert Scott, MD John Seaberg Steve Sjoblad Archie Smith Timothy M. Sullivan, MD James V. Toscano, President Emily Anne Tuttle Sheldon Z. Wert Minneapolis Heart Institute® and Minneapolis Heart Institute Foundation Physicians A special thanks to these physicians who have made significant contributions to philanthropy, research and education at MHIF. Raed H. Abdelhadi, MD Peter B. Alden, MD Jason Q. Alexander, MD Adrian K. Almquist, MD Richard Y. Bae, MD John E. Bernhardson, MD Shalini Bobra, MD M. Nicholas Burke, MD Durand E. Burns, MD Barry M. Cabuay, MD Ivan J. Chavez, MD Andrew H. Cragg, MD James A. Daniel, MD Timothy G. Dirks, MD Frazier Eales, MD David S. Feldman, MD, PhD Thomas F. Flavin, MD Björn P. Flygenring, MD James A. Furda, MD Charles C. Gornick, MD John N. Graber, MD Kevin J. Graham, MD Elizabeth Z. Grey, MD Kevin M. Harris, MD Robert G. Hauser, MD Timothy D. Henry, MD William T. Hession, MD Mark A. Houghland, MD Kasia Hryniewicz, MD David G. Hurrell, MD Desmond B. Jay, MD Randall K. Johnson, MD William T. Katsiyiannis, MD Thomas Knickelbine, MD Vibhu R. Kshettry, MD Casey M. Lawler, MD John R. Lesser, MD David Lin, MD Daniel L. Lips, MD Terrence F. Longe, MD James D. Madison, MD Barry J. Maron, MD Daniel Melby, MD Nader Moazami, MD Michael R. Mooney, MD Richard R. Nelson, MD Marc C. Newell, MD Quirino G. Orlandi, MD Luis A. Pagan-Carlo, MD Wesley R. Pedersen, MD Anil K. Poulose, MD Adnan Z. Rizvi, MD Robert S. Schwartz, MD Esther Shao, MD Scott W. Sharkey, MD Peter J. Stokman, MD Timothy M. Sullivan, MD Benjamin Sun, MD Chuen Y. Tang, MD Norma L. Thiessen, MD Jay H. Traverse, MD Alexander S. Tretinyak, MD Robert A. Van Tassel, MD Yale L. Wang, MD Contributors m a k i n g a d i f f e r e n c e . o n e s u p p o rt e r at a t i m e . MHIF is profoundly grateful for the financial contributions made by individuals and organizations who share our commitment to creating a world without heart disease.® This year, in an effort to conserve paper and valuable donor resources, we are pleased to recognize each donor on our website at www.mplsheart.org/2010annualreport It is time. 920 E 28th St Ste 100 • Minneapolis, MN 55407 (612)863.3833 • mplsheart.org Written by High Point Creative Designed by Zimmer | Madich